Solesis, a company specializing in biomaterials for the life sciences industry, completed the acquisition of Polyzen, a contract developer and manufacturer of custom medical-grade polymer components and products for the medical device and specialty industrial markets. Financial terms were not disclosed. “We are thrilled about what this new partnership will mean for our customers going forward. Polyzen enhances Solesis’ breadth of polymer-based technologies, know-how, and capabilities, all of which will enable us to continue to deliver innovative solutions to our customers,” Karen West, Solesis CEO.